|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Advanced Viral Research Corp., of Yonkers, N.Y., was awarded U.S. Patent No. 6,355,226 titled oTopical Treatment for Skin Disease and Eye Afflictions,o covering the use of Product R, the nontoxic peptide-nucleic acid immunomodulator developed by the company.
Alexion Pharmaceuticals Inc., of Cheshire, Conn., was issued U.S. Patent No. 6,355,245 titled oC-Specific Antibodies for the Treatment of Inflammatory Diseases.o The claims relate to the companyEs C5 complement inhibitor program and cover the composition and use of its lead drug candidates, eculizumab and pexelizumab, as well as other antibodies that bind to C5 and inhibit its inflammatory activity.
...
Related newspaper, magazine, and journal articles:
|
|
Article: Universal Display Announces: Advanced OLED Manufacturing ...
Business Wire;
January 22, 2002 ;
700+ words
... ... In addition to the OVPD patent, they include key patents in a number of areas ... TM)). Other recent patents provide exclusive worldwide ... Patterning Devices, U.S. patent number 6,294,398, issued September 25, 2001, is ...
|
|